Genomics, cell therapy could be future topics for regulatory harmonization, Glaxo chairman tells ICH 4.
Executive Summary
GENOMICS REGULATION HARMONIZATION IS POSSIBLE NEW FOCUS FOR ICH, Glaxo Wellcome Chairman Richard Sykes suggested at the fourth International Conference on Harmonization meeting in Brussels July 16. The development of gene therapies and genetic testing raise regulatory questions that have not yet been addressed, Sykes said, presenting an opportunity to create harmonized regulations as the state of technology advances.